Expanding the phenotype of TAB2 variants and literature review.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
11 2022
Historique:
revised: 18 04 2022
received: 30 01 2022
accepted: 19 06 2022
pubmed: 17 8 2022
medline: 12 10 2022
entrez: 16 8 2022
Statut: ppublish

Résumé

TAB2 is a gene located on chromosome 6q25.1 and plays a key role in development of the heart. Existing literature describes congenital heart disease as a common recognized phenotype of TAB2 gene variants, with evidence of a distinct syndromic phenotype also existing beyond this. Here we describe 14 newly identified individuals with nine novel, pathogenic TAB2 variants. The majority of individuals were identified through the Deciphering Developmental Disorders study through trio whole exome sequencing. Eight individuals had de novo variants, the other six individuals were found to have maternally inherited, or likely maternally inherited, variants. Five individuals from the same family were identified following cardiac disease gene panel in the proband and subsequent targeted familial gene sequencing. The clinical features of this cohort were compared to the existing literature. Common clinical features include distinctive facial features, growth abnormalities, joint hypermobility, hypotonia, and developmental delay. Newly identified features included feeding difficulties, sleep problems, visual problems, genitourinary abnormality, and other anatomical variations. Here we report 14 new individuals, including novel TAB2 variants, in order to expand the emerging syndromic clinical phenotype and provide further genotype-phenotype correlation.

Identifiants

pubmed: 35971781
doi: 10.1002/ajmg.a.62949
pmc: PMC9804770
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
TAB2 protein, human 0

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3331-3342

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V037307/1
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Mol Cell. 2000 Apr;5(4):649-58
pubmed: 10882101
Am J Med Genet A. 2017 Jul;173(7):1848-1857
pubmed: 28464518
Clin Genet. 2022 Feb;101(2):214-220
pubmed: 34741306
Hum Genome Var. 2021 Oct 29;8(1):40
pubmed: 34716296
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Am Coll Cardiol. 2018 Nov 6;72(19):2324-2338
pubmed: 30384889
Eur J Hum Genet. 2021 Nov;29(11):1669-1676
pubmed: 34456334
Lancet. 2015 Apr 4;385(9975):1305-14
pubmed: 25529582
Am J Med Genet A. 2022 Nov;188(11):3331-3342
pubmed: 35971781
Circulation. 2014 Dec 9;130(24):2162-72
pubmed: 25278099
Mol Genet Genomic Med. 2018 Apr 26;:
pubmed: 29700987
BMC Cardiovasc Disord. 2020 Jan 20;20(1):27
pubmed: 31959127
Am J Hum Genet. 2016 Aug 4;99(2):392-406
pubmed: 27426733
Am J Med Genet A. 2017 Jul;173(7):1739-1746
pubmed: 28498505
Congenit Heart Dis. 2016 Sep;11(5):452-461
pubmed: 27452334
Hum Mol Genet. 2012 Oct 15;21(R1):R37-44
pubmed: 22962312
Eur J Med Genet. 2020 Apr;63(4):103854
pubmed: 31981616
Clin Genet. 2018 Jan;93(1):126-133
pubmed: 28386937
Am J Hum Genet. 2010 Jun 11;86(6):839-49
pubmed: 20493459

Auteurs

Emily Woods (E)

Department of Paediatrics, Sheffield Children's Hospital NHS Foundation Trust, Sheffield, UK.

Imogen Marson (I)

Medical School, University of Sheffield, Sheffield, UK.

Emanuele Coci (E)

Department of Pediatrics, Prignitz Hospital, Brandenburg Medical School, Prignitz, Germany.
Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Michael Spiller (M)

Sheffield Diagnostic Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.

Ajith Kumar (A)

Department of Clinical Genetics, Great Ormond Street Hospital, London, UK.

Angela Brady (A)

Clinical Genetics Service, Northwick Park Hospital, London, UK.

Tessa Homfray (T)

Clinical Genetics Service, St George's Hospital, London, UK.

Richard Fisher (R)

Northern Genetics Service, Newcastle University Hospital NHS Trust, Newcastle, UK.

Peter Turnpenny (P)

Peninsula Clinical Genetics Service, Royal Devon and Exeter NHS Trust, Exeter, UK.

Julia Rankin (J)

Peninsula Clinical Genetics Service, Royal Devon and Exeter NHS Trust, Exeter, UK.

Farah Kanani (F)

Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.

Konrad Platzer (K)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Athina Ververi (A)

Department of Clinical Genetics, Great Ormond Street Hospital, London, UK.

Eleftheria Emmanouilidou (E)

Department of Paediatrics, General Hospital of Kavala, Kavala, Greece.

Nourxan Bourboun (N)

Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

George Giannakoulas (G)

Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Meena Balasubramanian (M)

Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH